Vivani Medical Inc (VANI)

Sector:
HEALTH CARE
Industry:
HEALTH CARE SUPPLIES
SIC:
ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS
CEO:
Scott Dunbar
Employees:
20
5858 HORTON STREET, SUITE 280, EMERYVILLE, CA, 94608
818-833-5000

Second Sight Medical Products, Inc. develops implantable visual prosthetics intended to deliver artificial vision to blind individuals. Orion Visual Cortical Prosthesis System, an implanted cortical stimulation device, is intended to provide useful artificial vision. The company was founded in 1998 and is headquartered in Sylmar, California.

Data derived from most recent annual or quarterly report
Market Cap 18.917 Million Shares Outstanding13.137 Million Avg 30-day Volume 36.73 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.06
Price to Revenue0.0 Debt to Equity0.0008 EBITDA-11.019 Million
Price to Book Value1.7081 Operating Margin0.0 Enterprise Value36.086 Million
Current Ratio9.691 EPS Growth0.625 Quick Ratio9.196
1 Yr BETA 1.1898 52-week High/Low 8.1 / 1.3 Profit Margin0.0
Operating Cash Flow Growth-56.4849 Altman Z-Score8.0739 Free Cash Flow to Firm -9.906 Million
View SEC Filings from VANI instead.

View recent insider trading info

Funds Holding VANI (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding VANI

Download CSV

Active Schedule 13D and 13G filings

Please sign in first

Recent Filings

Events (8k)

  • 8-K: filed on 2022-11-14:
    Item 2.02: Results of Operations and Financial Condition
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-10-17:
    Item 7.01: Regulation FD Disclosure
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-23:
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-09-02:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 2.01: Completion of Acquisition or Disposition of Assets
    Item 5.01: Changes in Control of Registrant
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-18:
    Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
    Item 7.01: Regulation FD Disclosure
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-08-05:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-29:
    Item 5.07: Submission of Matters to a Vote of Security Holders
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-07-18:
    Item 8.01: Other Events
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-21:
    Item 1.01: Entry into a Material Definitive Agreement
    Item 9.01: Financial Statements and Exhibits
  • 8-K: filed on 2022-06-16:
    Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
    Item 9.01: Financial Statements and Exhibits
  • Open Market Buys/Sells Last 60 Days

    Open Market Buys (P)

    10 Thousand total shares from 2 transactions

    Open Market Sells (S)

    none

    Exercise Derivative Conversion (M)

    none

    Current/Former Insiders

    Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

    DWYER DONALD CHIEF BUSINESS OFFICER

    • Officer
    10,000 2022-11-17 3

    MAKES BRIGID CFO

    • Officer
    50,000 2022-11-07 3

    WILLIAMS GREGG

    • Director
    • 10% Owner
    60,395 2022-11-07 8

    LARSON ALEXANDRA L.P.

    • Director
    17,387 2022-09-14 1

    BAKER WILFORD DEAN

    • Director
    288,043 2022-08-30 1

    MENDELSOHN AARON

    • Director
    1,132,601 2022-08-30 2

    MENDELSOHN ADAM CEO

    • Officer
    • Director
    0 2022-08-30 2

    LE TRUC COO

    • Officer
    0 2022-08-30 2

    PORTER LISA ELLEN CHIEF MEDICAL OFFICER

    • Officer
    0 2022-08-30 2

    DUNBAR SCOTT ACTING CEO

    • Officer
    2,383 2021-03-30 0

    RANDOLPH EDWARD DAVID VICE PRESIDENT-OPERATIONS

    • Officer
    2 2020-09-27 0

    SEDO EDWARD JONATHON CONTROLLER

    • Officer
    0 2020-09-04 0

    MCGUIRE JONATHAN WILL

    • Director
    20,469 2020-05-19 0

    RYAN WILLIAM PATRICK CHIEF OPERATING OFFICER

    • Officer
    2,261 2020-02-19 0

    BLAKE JOHN T CHIEF FINANCIAL OFFICER

    • Officer
    1,754 2020-02-19 0

    DORN JESSY DANA VP-CLIN & SCIENTIFIC AFFAIRS

    • Officer
    0 2020-02-12 0

    PFEFFER MATTHEW J

    • Director
    0 2019-06-04 0

    LINK WILLIAM J PHD

    • Director
    0 2019-06-04 0

    OKLAND STEPHEN D CHIEF COMMERCIAL OFFICER

    • Officer
    0 2019-02-19 0

    MILLER THOMAS B CHIEF FINANCIAL OFFICER

    • Officer
    78,354 2018-01-19 0

    COSENDAI GREGOIRE VP CLINICAL AFFAIRS

    • Officer
    23,484 2018-01-04 0

    GREENBERG ROBERT J. CHAIRMAN OF BOARD

    • Officer
    • Director
    172,911 2018-01-04 0

    JACQUES DAVID MURRAY VP-RESEARCH DEVELOPMENT

    • Officer
    0 2018-01-04 0

    ALFRED E. MANN LIVING TRUST

    INCUMED, LLC

    • 10% Owner
    No longer subject to file 2017-02-27 0

    MOSES JOHN ANTHONY COMMERCIAL VP AMERICAS

    • Officer
    1,754 2016-01-21 0

    RIPLEY ANNE-MARIE JULIETTE VP OF REGULATORY AFFAIRS

    • Officer
    0 2015-12-04 0

    MANN ALFRED E

    • Director
    • 10% Owner
    10,950,257 2015-06-01 0

    VERSANT VENTURES II LLC

    VERSANT VENTURE CAPITAL II, LP

    VERSANT SIDE FUND II, LP

    VERSANT AFFILIATES FUND II-A, LP

    ATWOOD BRIAN G

    LINK WILLIAM J PHD

    MILDER DONALD B

    COLELLA SAMUEL D

    JAFFE ROSS A MD

    • Director
    • 10% Owner
    4,492,975 2014-12-02 0

    VERSANT VENTURES II LLC

    VERSANT VENTURE CAPITAL II, LP

    VERSANT SIDE FUND II, LP

    VERSANT AFFILIATES FUND II-A, LP

    ROBERTSON REBECCA B

    BOLZON BRADLEY J PHD

    WARDEN CHARLES M

    LUBASH BARBARA N

    • 10% Owner
    4,492,975 2014-12-02 0

    MECH BRIAN VERNON VP OF BUSINESS DEVELOPMENT

    • Officer
    0 2014-11-18 0

    Insider Transactions Last 60 Days

    Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
    Disposed
    Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

    DWYER DONALD - Officer CHIEF BUSINESS OFFICER

    2022-11-21 11:11:37 -0500 2022-11-18 P 5,000 $1.40 a 10,000 direct 2.8986 2.8986 2 0.0 1

    DWYER DONALD - Officer CHIEF BUSINESS OFFICER

    2022-11-21 11:11:37 -0500 2022-11-17 P 5,000 $1.50 a 5,000 direct 2.8986 2.8986 2 0.0 1

    WILLIAMS GREGG - Director - > 10% Owner trust

    2022-11-09 20:09:17 -0500 2022-11-07 A 60,395 a 60,395 indirect

    MAKES BRIGID - Officer CFO

    2022-11-09 20:11:04 -0500 2022-11-07 A 50,000 a 50,000 direct

    * -

    Transaction Code Definitions
    Code Definition
    A Grant, award or other acquisition pursuant to Rule 16b-3(d)
    C Conversion of derivative security
    D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
    E Expiration of short derivative position
    F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
    G Bona fide gift
    H Expiration (or cancellation) of long derivative position with value received
    I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
    J Other acquisition or disposition
    L Small acquisition under Rule 16a-6
    M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
    O Exercise of out-of-the-money derivative security
    P Open market or private purchase of non-derivative or derivative security
    S Open market or private sale of non-derivative or derivative security
    U Disposition pursuant to a tender of shares in a change of control transaction
    W Acquisition or disposition by will or the laws of descent and distribution
    X Exercise of in-the-money or at-the-money derivative security
    Z Deposit into or withdrawal from voting trust

    IBR Securities Loan Availability

    Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

    Security Date/Time Rebate Rate Fee Rate Shares Available
    VIVANI MEDICAL INC VANI 2022-11-25 22:15:03 UTC -1.4831 5.3031 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 21:45:04 UTC -1.3585 5.1785 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 21:15:03 UTC -1.3585 5.1785 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 20:45:03 UTC -1.3585 5.1785 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 20:15:03 UTC -1.3585 5.1785 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 19:45:04 UTC -1.3585 5.1785 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 19:15:03 UTC -1.3585 5.1785 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 18:45:03 UTC -1.3512 5.1712 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 18:15:03 UTC -1.3512 5.1712 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 17:45:04 UTC -1.3512 5.1712 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 17:15:03 UTC -1.3512 5.1712 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 16:45:04 UTC -1.4749 5.2949 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 16:15:03 UTC -1.4749 5.2949 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 15:45:03 UTC -1.4749 5.2949 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 15:15:03 UTC -1.4749 5.2949 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 14:45:04 UTC -1.4749 5.2949 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 14:15:04 UTC -1.4749 5.2949 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 13:45:03 UTC -1.5311 5.3511 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 13:15:03 UTC -1.5311 5.3511 1100000
    VIVANI MEDICAL INC VANI 2022-11-25 12:45:03 UTC -1.5311 5.3511 1100000

    Current Active Short Positions

    Holder Issuer Net Short Position Position Date Origin
    Blackstone Alternative Investment Funds- Blackstone Alternative Multi-Strategy Fund VANI -1466.0 shares, $-3342.48 2022-09-30 N-PORT

    No recent transactions

    *** To see all congressional transactions (since 2022) for this stock, please use the congressional transaction search page***

    Elevate your investments